Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of a polypeptide specifically binding to trb3 in the treatment of abdominal aortic aneurysm

An abdominal aortic aneurysm and species-specific technology, applied in the direction of medical preparations containing active ingredients, drug combinations, anti-tumor drugs, etc., can solve the problem of lack of TRB3 protein inhibitors and achieve significant curative effect

Active Publication Date: 2020-07-14
INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The technical problem to be solved by the present invention is to provide a polypeptide that can specifically bind to TRB3 and its application in the preparation of drugs for the treatment or prevention of abdominal aortic aneurysms in view of the current lack of effective TRB3 protein inhibitors.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of a polypeptide specifically binding to trb3 in the treatment of abdominal aortic aneurysm
  • Application of a polypeptide specifically binding to trb3 in the treatment of abdominal aortic aneurysm
  • Application of a polypeptide specifically binding to trb3 in the treatment of abdominal aortic aneurysm

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Example 1: Using surface plasmon resonance to screen peptides that bind to TRB3 protein.

[0059] First, the P62 protein is truncated into different polypeptide fragments, and the peptides are synthesized with a peptide solid-phase synthesizer. This process is carried out by Beijing Saibaisheng Gene Co., Ltd. EXAMPLES The entire screening process was carried out in a surface plasmon resonance instrument BiacoreT200.

[0060] The screening method is as follows:

[0061] 1. The purified protein TRB3 (purchased from R&D Company) was coupled to a CM5 chip (purchased from GE Company) through amino groups, unbound protein was washed away at a flow rate of 10 μL / min, and the surface of the chip was equilibrated for 2 hours.

[0062] 2. Automatically inject 250 μL of different concentrations of polypeptide fragments (200, 50, 12.5, 6.25 nM), and the whole process is carried out at 25°C. The buffer used was HBS-EP buffer (0.01M HEPES, 0.15M NaCl, 3mM EDTA, 0.005% surfactant). ...

Embodiment 2

[0067] Example 2: ELISA method to verify the binding of peptide A2 to protein TRB3.

[0068] The specific operation steps are as follows:

[0069] 1. Dilute human TRB3 protein and bovine serum albumin (BSA) to 10 μg / ml with PBS, add 100 μl to each well, and coat a 96-well ELISA plate at 4°C overnight.

[0070] 2. Wash three times with PBS containing 0.1% Tween-20. The plates were coated with 200 μl of blocking solution (10% BSA--PBS), and coated at 37° C. for 2 hours.

[0071] 3. Pour off the coating solution, add 200 μl of 1 μg / ml polypeptide B1, A2 and B3 solutions, and set up positive control wells, add 200 μl of 1 μg / ml P62 protein solution, and incubate at 37°C for 1 hour.

[0072] 4. Wash five times with PBS containing 0.1% Tween-20. Add 100 μl anti-M13 monoclonal antibody diluted with blocking solution 1:4000 to each well, and incubate at room temperature for 1 h.

[0073] 5. Wash six times with PBS containing 0.1% Tween-20. Prepare substrate chromogenic solution (...

Embodiment 3

[0076] Example 3: The method of competition ELISA verifies that peptide A2 can compete for the binding of TRB3 and P62 protein.

[0077] The specific operation steps are as follows:

[0078] 1. Dilute human TRB3 protein and BSA to 10 μl / ml with PBS, add 100 μl to each well, and coat 96-well ELISA plate at 4°C overnight.

[0079] 2. Wash three times with PBS containing 0.1% Tween-20. The plates were coated with 200 μl of blocking solution (10% BSA--PBS), and coated at 37° C. for 2 hours.

[0080] 3. Pour off the coating solution, add 200 μl of 1 μg / ml P62 protein solution, and incubate at 37°C

[0081] 1h.

[0082] 4. Wash five times with PBS containing 0.1% Tween-20. Add 100 μl of horseradish catalase-labeled polypeptide A2 diluted with blocking solution to each well, and incubate at room temperature for 1 h.

[0083] 5. Wash six times with PBS containing 0.1% Tween-20. Prepare substrate chromogenic solution (100mmol / L sodium acetate, pH 6.0, add 10μl 30% hydrogen peroxi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of polypeptide specific-binding TRB3 in treating or preventing abdominal aortic aneurysm. The amino acid sequence of the polypeptide is showed as SEQ ID NO:1. The polypeptide derivative is a chimeric peptide formed by the polypeptide connecting with a cell penetrating peptide or a dosage form formed by the polypeptide coordinated with a drug excipient. The polypeptide is screened by the surface plasma resonance (Biacore) method, and can specifically bind to TRB3 and blockade the combination of TRB3 and P62 protein. Meanwhile, the polypeptide derivative Pep2-A2 can treat the mice abdominal aortic aneurysm by knocking-out ApoE inducted by angiotensin II. Thus, the polypeptide and the polypeptide derivative can be used as a novel inhibitor for TRB3, and can be used in exploiting vaccine or medicament for inhibiting abdominal aortic aneurysm.

Description

technical field [0001] The invention relates to the application of a polypeptide and its derivatives in the preparation of medicines for treating or preventing abdominal aortic aneurysms. Background technique [0002] Abdominal aortic aneurysm refers to an expansive mass in the abdominal aorta that pulses laterally and anteroposteriorly, showing aneurysmal expansion. Usually, an increase of more than 50% in the diameter of the aorta can be defined as an aneurysm. The lesion of this disease has a very high risk of rupture. Once the tumor ruptures, it is often accompanied by shock, and the mortality rate is as high as 78%-92%, which seriously threatens human health. When the tumor is not ruptured, the patient is often accompanied by severe pain around the umbilicus and in the middle and upper abdomen, and concurrently with diseases such as atherosclerosis, diabetes, lower extremity arterial embolism, and hydronephrosis, which seriously affect the quality of life of the patient...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K38/08A61K38/10A61K38/16A61P35/00
Inventor 胡卓伟付小明李珂花芳
Owner INST OF MATERIA MEDICA CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com